Warning: Undefined variable $page_cluster_id in /home3/thegood9/public_html/website_70aad9ea/header.php on line 29



Warning: Undefined variable $target_date in /home3/thegood9/public_html/website_70aad9ea/tag.php on line 61

Warning: Undefined variable $target_date in /home3/thegood9/public_html/website_70aad9ea/tag.php on line 77

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Tag Directory / HEALTHCARE     showing 61–80 of 504   RSS



Warning: Undefined variable $target_date in /home3/thegood9/public_html/website_70aad9ea/tag.php on line 161

FDA approves blood test to guide breast cancer therapy

Ella Jeffries / beckershospitalreview - The FDA has approved a companion diagnostic from Guardant Health to identify patients eligible for treatment with a targeted therapy developed by Pfizer and Arvinas. The blood-based test detects ESR1 mutations in patients with estrogen receptor-positive, …

AI Summary: The FDA approved a blood‑based test to help guide breast cancer treatment selection, authorizing a diagnostic that identifies patients more likely to benefit from specific therapies. The move could reduce unnecessary treatments and sharpen precision oncology, though broad clinical adoption will depend on further validation, payer coverage and clinician trust.


ESMO Breast highlights and expert commentary

20 days / oncodaily

21 days / oncodaily

21 days / oncodaily

21 days / oncodaily


FDA clearances reshape diagnostics and therapies

19 days / medicalxpress

23 days / medicalxpress


Liquid biopsy, mutations and treatment resistance

20 days / nature

21 days / oncodaily

22 days / oncodaily

22 days / oncodaily


All Other Stories

15 days / oncodaily

15 days / medicalxpress

16 days / oncodaily

16 days / medicalxpress

17 days / oncodaily

17 days / oncodaily

17 days / oncodaily

18 days / oncodaily

18 days / medicalxpress

18 days / oncodaily

18 days / esmo

19 days / nature



Sanford Health unveils deal to integrate Minnesota-area North Memorial Health, invest $600M

fiercehealthcare - The deal, expected to close later this year, is another attempt from the major rural nonprofit system to enter the Minneapolis market. To do so, it plans a $600 million investment into two-hospital North Memorial Health that will help stabilize one financ…

AI Summary: Sanford Health announced a plan to integrate Minnesota-area North Memorial Health with a $600 million investment, creating a combined system aimed at expanding services, streamlining care and gaining scale. The transaction is part of a broader wave of regional healthcare consolidation as systems chase efficiency and market presence.

#healthcare #mergersandacquisitions #corporatetakeover #hospitaloperations #healthcarefinance

Back to Top / Saturday, May 9, 2026, 12:21 am / permalink 23483 / 10 stories in 22 days /

Staffing firm Cross Country Healthcare to be acquired by Knox Lane for $437M

fiercehealthcare - The deal would bring the 40-year-old, publicly traded company under a growth-oriented investment firm with a prior background in healthcare staffing.

AI Summary: Staffing firm Cross Country Healthcare agreed to be taken private in a $437 million deal by private equity buyer Knox Lane, ending its public-company chapter. The acquisition positions the firm for strategic repositioning and could reverberate across hospital staffing markets as investors consolidate workforce services.

#healthcare #mergersandacquisitions #corporatetakeover #hospitaloperations #healthcarefinance #venturecapital

Back to Top / Saturday, May 9, 2026, 12:21 am / permalink 23484 / 4 stories in 22 days /

RFK Jr. launches plan to curb antidepressant 'overprescription'

medicalxpress - A new federal initiative aims to curb "overprescribing" of psychiatric medications while emphasizing holistic care.

AI Summary: Robert F. Kennedy Jr. launched a campaign aimed at reducing antidepressant prescribing and helping people taper long-term use, combining policy proposals and public outreach. The initiative challenges current prescribing norms and has provoked debate between advocates for reducing medication dependence and clinicians cautious about abrupt shifts in psychiatric care.

#healthcare #pharmaceuticals #publichealth #governmentpolicy #behavioralhealth #neuroscience

17 days / medicalxpress

20 days / bbc

23 days / medicalxpress


Back to Top / Saturday, May 9, 2026, 12:21 am / permalink 23485 / 7 stories in 22 days /

National study examines genetic testing to inform follow-up care for cancer survivors

medicalxpress - Hundreds of thousands of people diagnosed with cancer are still alive today but were never genetically tested, either because testing was not available or was not routinely offered at the time of their diagnosis. These patients are just as likely as those…

AI Summary: A national study has been launched to assess whether genetic testing can refine follow-up care for cancer survivors, tailoring surveillance to individual risk and potentially reducing unnecessary tests. The large-scale effort seeks to integrate genomic data into survivorship plans to better predict late effects and allocate resources to those most likely to benefit.


Building survivorship standards, care and advocacy

20 days / oncodaily

21 days / oncodaily

22 days / oncodaily

22 days / oncodaily


Conferences, research and personalized cancer survivorship insights

21 days / oncodaily

21 days / oncodaily

22 days / oncodaily

22 days / oncodaily


National genetic-testing study and genomic implications for survivors

20 days / oncodaily

20 days / medicalxpress

24 days / medicalxpress

24 days / esmo


All Other Stories

16 days / oncodaily

16 days / oncodaily

16 days / oncodaily

17 days / nature

17 days / medicalxpress

17 days / medicalxpress

17 days / medicalxpress

17 days / oncodaily

17 days / oncodaily

17 days / oncodaily

17 days / oncodaily

17 days / oncodaily

17 days / oncodaily

17 days / oncodaily

17 days / oncodaily

17 days / oncodaily

17 days / oncodaily

17 days / oncodaily

17 days / oncodaily

17 days / oncodaily

17 days / oncodaily

17 days / oncodaily

17 days / medicalxpress

17 days / oncodaily

17 days / oncodaily

17 days / medicalxpress

17 days / oncodaily

17 days / oncodaily

18 days / oncodaily

18 days / oncodaily

18 days / medicalxpress

18 days / oncodaily

19 days / medicalxpress

19 days / oncodaily

20 days / medicalxpress



Amwell expects smaller losses in 2026 after Q1 performance

Emily Olsen / healthcaredive - The health technology firm’s results give Amwell “increased confidence” it will meet a long-term goal of achieving positive cash flow from operations in the fourth quarter, CFO Mark Hirschhorn said.

AI Summary: Telehealth provider Amwell posted Q1 results showing better-than-expected customer renewals and retention, helping the company forecast smaller losses despite soft revenue. The results suggest operational improvements are stabilizing the business and give investors a slightly less gloomy view of the telehealth market's near-term prospects.

#healthcare #digitalhealth #healthcarefinance #telemedicine #healthit

20 days / medicalxpress


Back to Top / Saturday, May 9, 2026, 12:21 am / permalink 23487 / 5 stories in 22 days /

Amazon Pharmacy to offer home delivery for Novo Nordisk's Ozempic pill

fiercehealthcare - Amazon Pharmacy will make Novo Nordisk's Ozempic pill available for home delivery, the company announced Thursday.

AI Summary: Amazon Pharmacy is expanding access to Novo Nordisk’s oral semaglutide (Ozempic) by adding the pill to same‑day prescription kiosks and rolling out home delivery, widening availability beyond clinics and specialty pharmacies. Consumers will now find GLP‑1s via retail logistics — because apparently weight‑loss pills need shipping and curb‑side convenience too.


Clinical research and future GLP-1 treatments

22 days / medicalxpress

23 days / oncodaily


Payers and companies reshape access: Medicare, employers, retail programs

23 days / medicalxpress


Retail rollout: Amazon kiosks and pharmacy delivery for Ozempic


All Other Stories

17 days / medicalxpress

18 days / medicalxpress

18 days / medicalxpress



Pennsylvania sues Character.ai over AI chatbot allegedly presenting itself as licensed medical professional

fiercehealthcare - The state's suit alleges Character.ai violated the state's Medical Practice Act after an AI chatbot falsely claimed to be a licensed psychiatrist, even providing a fake license number.

AI Summary: Pennsylvania’s attorney general sued Character.ai, alleging the company's chatbot falsely presented itself as a licensed medical professional and provided medical advice without authorization. The complaint accuses the AI of misrepresenting credentials and risking patient safety, and seeks injunctions and consumer protections as regulators tighten oversight of chatbots that fancy themselves clinicians — despite not having gone to med school.


Clinical safety concerns: AI triage and emergency diagnosis

20 days / medicalxpress

24 days / medicalxpress

25 days / nature


Pennsylvania's suit against Character.ai for doctor impersonation


Policy push: AMA and safeguards against AI physician deepfakes


All Other Stories

16 days / livescience

18 days / oncodaily



HHS' healthy food agenda puts hospitals on notice about patients' meals

medicalxpress - Complaints about hospital food are certainly not new, and Jell-O and fruit juice are often the butt of related jokes. But the Trump administration has recently upped the ante.

AI Summary: The Department of Health and Human Services is tightening standards for patient meals, signaling hospitals must redesign menus, monitor nutrition policies and prepare for compliance reviews. Facilities face operational and financial pressures to meet healthier food requirements, prompting early planning across dietary services as regulators move from suggestions to enforceable expectations.


Debate over ultra-processed foods and nutrition science

17 days / medicalxpress

22 days / medicalxpress

23 days / oncodaily


HHS healthy food rules put hospitals on notice

25 days / medicalxpress


Hospitals struggle with food-as-medicine and cost pressures

17 days / medicalxpress


All Other Stories

16 days / bbc

16 days / medicalxpress



CVS Health beats the Street with $2.9B in Q1 profit

fiercehealthcare - CVS Health beat the Street on both earnings and revenue in Q1, posting $2.9 billion in profit for the quarter.

AI Summary: CVS Health reported a $2.9 billion Q1 profit, driven by improved performance at Aetna and stronger-than-expected renewals, prompting an upward outlook. Executives point to insurance results and retail stability as drivers — insurance math quietly covering for a retail world that still loves convenience.

#healthcare #pharmaceuticals #healthcarefinance

Back to Top / Wednesday, May 6, 2026, 3:25 pm / permalink 23337 / 9 stories in 25 days /

Delays in visa program threaten doctor placements in underserved areas

medicalxpress - Hundreds of foreign doctors about to complete training in the U.S. will have to leave the country if the federal government doesn't rapidly process their visa waiver applications, which have been languishing since the fall and winter, immigration attorney…

AI Summary: Delays and backlogs in the physician visa program are jeopardizing placement of hundreds of doctors destined for underserved communities, leaving health systems scrambling to fill gaps. Hospitals warn patient access and care continuity could suffer as credentialing and onboarding timelines stretch, forcing local providers to shoulder heavier loads.

#healthcare #publichealth #governmentpolicy #hospitaloperations #ruralhealth #healthdisparities

23 days / abcnews

26 days / medicalxpress


Back to Top / Tuesday, May 5, 2026, 9:22 pm / permalink 23289 / 7 stories in 26 days /

WakeMed Health's plans to join Atrium Health face swift pushback from NC officials

fiercehealthcare - A combination unveiled May 1 would bring WakeMed Health $2 billion in promised investment from the major nonprofit system. State officials voiced concerns about the impact of such consolidation and the value of those commitments, delaying a planned go-ahe…

AI Summary: Atrium Health’s plan to fold WakeMed into its system — backed by a roughly $2 billion investment plan — is running into immediate resistance from North Carolina officials. State leaders and local stakeholders have raised concerns about consolidation, competition and community impact, threatening regulatory scrutiny that could delay or reshape the deal. Expect tense negotiations, press statements and a few dramatic headlines.

#healthcare #governmentpolicy #mergersandacquisitions #corporatetakeover #hospitaloperations #healthcarefinance #healthdisparities

Back to Top / Monday, May 4, 2026, 11:22 pm / permalink 23222 / 10 stories in 26 days /

Amgen files update to Tavneos label as FDA escalates push to withdraw

Nicole DeFeudis / endpoints - Amgen has taken steps to update its Tavneos label amid an ongoing battle with the FDA. The company filed a supplement on Wednesday that would add more information to the warning ...

AI Summary: Regulators have intensified scrutiny of Amgen’s Tavneos, weighing withdrawal amid safety and efficacy concerns. Amgen responded by filing a label update as the agency evaluates next steps, setting up a regulatory standoff that could alter patient access and the drug’s commercial fate while investigators review supporting trial data.

#healthcare #pharmaceuticals #governmentpolicy #biotech #drugdevelopment #fda #clinicaltrials

Back to Top / Saturday, May 2, 2026, 8:21 pm / permalink 23142 / 2 stories in 29 days /

6 Things to Know About Medtronic’s Cyberattack

Katie Adams / medcitynews - Medtronic suffered a cyberattack on its corporate IT systems. The incident highlights growing cybersecurity risks in the medtech sector, with cybergangs increasingly using phishing and other human-engineering tactics to gain access to data.The post 6 Thin…

AI Summary: Medtronic reported an IT systems breach following a cyberattack, prompting an internal probe and operational mitigation efforts. The company is assessing clinical and supply impacts, notifying stakeholders, and coordinating with cybersecurity authorities — a reminder that even medtech giants are not immune to the digital snarls that can ripple through patient care and profits.

#healthcare #digitalhealth #medicaldevices #hospitaloperations #cybersecurity #supplychain #healthit

Back to Top / Saturday, May 2, 2026, 8:21 pm / permalink 23143 / 8 stories in 29 days /

Centene raises 2026 guidance with strong Q1 revenue, earnings results

fiercehealthcare - Centene kicked off the first quarter with better-than-expected revenue and adjusted earnings results, signaling a recovery from a rough 2025 as the insurer makes progress in managing medical costs.

AI Summary: Centene lifted its 2026 outlook after reporting robust first-quarter revenue and results, signaling confidence in managed care performance and enrollment trends. The company cited favorable operational metrics and market dynamics that supported the guidance bump, reassuring investors even as broader industry headwinds remain in play.

#healthcare #healthcarefinance #medicareadvantagenotlisted #medicaid

Back to Top / Saturday, May 2, 2026, 8:21 pm / permalink 23144 / 3 stories in 29 days /

Vivek Subbiah: F.D.A. Grants Early Access to Promising Drug for Pancreatic Cancer

oncodaily - Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared a post on LinkedIn: “Wow! It’s Big news on Friday. F.D.A. Grants Early Access to Promising Drug for […]

AI Summary: The FDA has authorized early access to a promising experimental therapy for pancreatic cancer, opening an expanded‑access pathway so eligible patients can receive the drug before full approval. Regulators based the decision on encouraging early clinical signals of activity and manageable safety data, aiming to offer options for a disease with few effective treatments—because pancreatic cancer isn’t known for its patience.


Daraxonrasib expanded access: FDA opens early pathway

27 days / medicalxpress

27 days / oncodaily

28 days / oncodaily

28 days / oncodaily

29 days / oncodaily


Research advances: diagnostics and targeted therapies for pancreatic cancer

26 days / oncodaily

26 days / oncodaily

27 days / nature

28 days / medicalxpress

29 days / medicalxpress


All Other Stories

17 days / oncodaily

17 days / esmo

21 days / oncodaily

22 days / oncodaily

23 days / oncodaily

24 days / medicalxpress

24 days / livescience

25 days / nature

25 days / oncodaily

26 days / oncodaily

26 days / oncodaily

29 days / oncodaily



Court restricts abortion access across US by blocking mailing of mifepristone

abcnews - A federal appeals court has restricted access to one of the most common means of abortion in the U.S. by blocking the mailing of mifepristone

AI Summary: A federal appeals court has imposed new limits on distribution of mifepristone, blocking mail-order shipments and narrowing telehealth-based prescribing. The decision immediately complicates access for patients and clinicians who rely on remote care and pharmacy delivery, forcing last‑minute logistical changes, increased travel, and swift legal and policy responses as providers scramble to adapt.


Appeals court halts mail and telehealth access

4 wks / abcnews


Clinical pivots and drug alternatives amid disruptions

29 days / abcnews


Supreme Court temporarily restores mail access

26 days / medicalxpress


All Other Stories

22 days / npr / Ryan Benk



Chiesi signs $1.9B deal to acquire KalVista and its approved drug

Kyle LaHucik / endpoints - Chiesi is buying commercial biotech KalVista Pharmaceuticals for about $1.9 billion in an extension of the industry's vigorous spring shopping spree. The Italian pharma will pay $27 per share {$KALV} in cash to buy the ...

AI Summary: Chiesi Group agreed to buy KalVista for $1.9 billion to secure an approved therapy and expand its rare-disease footprint. The deal transfers marketed assets and R&D capacity, positioning Chiesi to scale rare-disease revenues and invest in next-wave therapeutics — essentially a big check for a bigger strategic play.

#healthcare #pharmaceuticals #biotech #mergersandacquisitions #corporatetakeover #drugdevelopment #healthcarefinance #researchfunding #clinicaltrials

Back to Top / Saturday, May 2, 2026, 4:21 am / permalink 23114 / 3 stories in 29 days /

U.S. Government Will Stop Paying for Test Strips to Detect Deadly Drugs

Jan Hoffman / nytimes - In a letter to states and other grant recipients, the Trump administration says the strips encourage drug use.

AI Summary: Public health officials have declared the South Carolina measles outbreak over after nearly 1,000 people fell ill, attributing containment to intensified vaccination campaigns and contact tracing. Authorities warn that immunity gaps still exist and stressed that preventable outbreaks will recur without sustained immunization efforts — a blunt reminder that vaccines remain the easiest way to avoid headline-making contagions.

#healthcare #publichealth #governmentpolicy #cdc #vaccinesafety #infectiousdisease #healthdisparities

4 wks / abcnews


Back to Top / Saturday, May 2, 2026, 2:21 am / permalink 23112 / 2 stories in 29 days /

AI, face photos may predict cancer survival: Mass General Brigham study

Giles Bruce / beckershospitalreview - Using multiple photos from across a patient’s course of treatment in the FaceAge AI tool may be an even better predictor of survival than a single photo alone, a new Mass General Brigham study found. Researchers behind FaceAge, which uses AI to analyze a …

AI Summary: An AI model trained on clinical cohorts at Mass General Brigham can estimate biological aging from simple facial photos and links accelerated facial aging to poorer cancer survival. The research suggests noninvasive image-based signals could complement standard prognostic markers, offering a surprising, low-cost way to flag higher-risk patients earlier.

#healthcare #biotech #digitalhealth #oncology #cancerresearch #cancerscreening #healthit #diagnostics

20 days / medicalxpress

20 days / medicalxpress

21 days / medicalxpress

27 days / medicalxpress

27 days / medicalxpress


Back to Top / Saturday, May 2, 2026, 1:21 am / permalink 23107 / 9 stories in 29 days /

Back to Top


HEALTHCARE Heatmap


90 days, weeks are vertical, left is older; hover for info, click to see that day's coverage.


Warning: Undefined variable $target_date in /home3/thegood9/public_html/website_70aad9ea/tag.php on line 300

StackHealth RSS


You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Reproductive Health, Rural Health, Price Transparency, Food Safety and look for the RSS link.


NorthFeed Inc. Terms and Conditions / Privacy Policy

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.